References


  1. Field MJ, Lohr KN, eds. Clinical practice guidelines: Directions for a New Program. National Academy Press. Washington DC;1990.

  2. Public Policy Committee of the American College of Physicians, Ginsburg JA, Doherty RB, et al. Achieving a high-performance health care system with universal access: what the United States can learn from other countries. Ann Intern Med 2008 Jan.;148:55-75.

  3. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA 2008;299:2789-2791.

  4. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med 2003;138:273-287.

  5. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med 2003;138:288-298.

  6. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-1322.

  7. Stulberg JJ, Delaney CP, Neuhauser DV, et al. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010;303:2479-2485.

  8. Berenguer CM, Ochsner MG, Lord SA, Senkowski CK. Improving surgical site infections: using National Surgical Quality Improvement Program data to ­institute Surgical Care Improvement Project protocols in improving surgical outcomes. J Am Coll Surg 2010;210:737-743.

  9. Woolf SH, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318:527-530.

  10. Wolf JS Jr, Hubbard H, Faraday MM, Forrest JB. Clinical practice guidelines to inform evidence-based clinical practice. World J Urol 2011;29:303-309.

  11. Woolf SH. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992;152:946-952.

  12. Buie WD. Clinical practice guidelines: appraising the evidence. Dis Colon Rectum 2010;53:1107-1109.

  13. Qaseem A, Snow V, Owens DK, et al. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med 2010;153:194-199.

  14. Harpole LH, Kelley MJ, Schreiber G, et al. Assessment of the scope and quality of clinical practice guidelines in lung cancer. Chest 2003;123:7S-20S.

  15. Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol 2011;29:186-191.

  16. Shaneyfelt TM, Centor RM. Reassessment of clinical practice guidelines: go gently into that good night. JAMA 2009;301:868-869.

  17. Detsky AS. Sources of bias for authors of clinical practice guidelines. CMAJ 2006;1751033,1035.

  18. Report: Clinical Practice Guidelines We Can Trust page. Institute of Medicine of the National Academies webpage. Available at www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx. Accessed on October 11, 2012. 

  19. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007;178:2314-2330.

  20. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997-1008.

  21. Oxford Centre for Evidence-Based Medicine—Levels of Evidence (March 2009) page. Center for Evidence Based Medicine website. Available at http://www.cebm.net/index.aspx?o=1025. Accessed on ­October 11, 2012.

  22. Sylvester RJ, van der Meijden APM, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2,596 patients from seven EORTC trials. Eur Urol 2006;49:466-477.

  23. Fernandez-Gomez J, Madero R, Solsona E, et al. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol 2009;182:2195-2203.

  24. McGivney WT. NCCN Guidelines and Their Impact on Coverage Policy. J Natl Compr Canc Netw 2010;8:625.

  25. NCCN Guidelines page. National Comprehensive Cancer Network website. Available at www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed on October 11, 2012. 

  26. Hollingsworth JM, Zhang Y, Krein SL, et al. Understanding the variation in treatment intensity among patients with early stage bladder cancer. Cancer 2010;116:3587-3594.

  27. Hollingsworth JM, Zhang YS, Miller DC, et al. Identifying Better Practices for Early-stage Bladder Cancer. Med Care 2011;49:1112-1117.

  28. Schrag D, Hsieh LJ, Rabbani F, et al. Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst 2003;95:588-597.

  29. Chamie K, Saigal CS, Lai J, et al. Compliance with guidelines for patients with bladder cancer: Variation in the Delivery of Care. Cancer 2011;117:5392-5401.

  30. Bolenz C, Ho R, Nuss GR, et al. Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival. BJU Int 2010;106:1324-1329.

  31. Miller DC, Murtagh DS, Suh RS, et al. Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. J Urol 2011;186:844-849.